Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)
USD 4.0
(0.0%)
USD 4.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 61.22 Million USD | 73.98% |
| 2022 | 35.19 Million USD | -91.35% |
| 2021 | 406.83 Million USD | 45.81% |
| 2020 | 279.02 Million USD | 5224.86% |
| 2019 | 5.23 Million USD | -95.23% |
| 2018 | 109.95 Million CNY | 531.04% |
| 2017 | 17.42 Million CNY | 7.81% |
| 2016 | 16.16 Million CNY | 124.49% |
| 2015 | 7.19 Million CNY | -38.9% |
| 2014 | 11.78 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 842.23 Million CNY | 0.12% |
| 2024 Q3 | 397.23 Million CNY | -1.87% |
| 2024 Q2 | 404.81 Million CNY | -6.88% |
| 2023 Q4 | 857.33 Million CNY | -10.2% |
| 2023 Q3 | 954.68 Million CNY | 28.72% |
| 2023 FY | 61.22 Million USD | 73.98% |
| 2023 Q1 | 40.84 Million USD | 16.08% |
| 2023 Q2 | 741.67 Million CNY | 1715.63% |
| 2022 Q3 | 9.78 Million USD | -97.8% |
| 2022 Q4 | 35.19 Million USD | 259.7% |
| 2022 FY | 35.19 Million USD | -91.35% |
| 2022 Q1 | 398.32 Million CNY | -2.09% |
| 2022 Q2 | 445.64 Million CNY | 11.88% |
| 2021 Q4 | 406.83 Million CNY | 8.44% |
| 2021 FY | 406.83 Million USD | 45.81% |
| 2021 Q1 | 283.04 Million CNY | 1.44% |
| 2021 Q2 | 323.88 Million CNY | 14.43% |
| 2021 Q3 | 375.18 Million CNY | 15.84% |
| 2020 Q2 | 379.32 Million CNY | -0.28% |
| 2020 Q3 | 237.15 Million CNY | -37.48% |
| 2020 Q4 | 279.02 Million CNY | 17.65% |
| 2020 FY | 279.02 Million USD | 5224.86% |
| 2020 Q1 | 380.4 Million CNY | 120.98% |
| 2019 Q3 | 175.34 Million CNY | 91.47% |
| 2019 Q2 | 91.58 Million CNY | 3980.03% |
| 2019 Q4 | 172.13 Million CNY | -1.83% |
| 2019 Q1 | 2.24 Million CNY | -97.96% |
| 2019 FY | 5.23 Million USD | -95.23% |
| 2018 Q1 | 16.06 Million CNY | -7.78% |
| 2018 Q3 | 4.58 Million CNY | -16.82% |
| 2018 Q2 | 5.51 Million CNY | -65.69% |
| 2018 Q4 | 109.95 Million CNY | 2297.53% |
| 2018 FY | 109.95 Million CNY | 531.04% |
| 2017 Q3 | 24.6 Million CNY | 52.94% |
| 2017 Q1 | 6.16 Million CNY | -61.83% |
| 2017 FY | 17.42 Million CNY | 7.81% |
| 2017 Q4 | 17.42 Million CNY | -29.18% |
| 2017 Q2 | 16.08 Million CNY | 160.78% |
| 2016 Q3 | 6.1 Million CNY | 7.02% |
| 2016 FY | 16.16 Million CNY | 124.49% |
| 2016 Q4 | 16.16 Million CNY | 164.96% |
| 2016 Q2 | 5.7 Million CNY | -14.54% |
| 2016 Q1 | 6.66 Million CNY | -7.36% |
| 2015 FY | 7.19 Million CNY | -38.9% |
| 2015 Q3 | 7.5 Million CNY | -60.76% |
| 2015 Q4 | 7.19 Million CNY | -4.08% |
| 2015 Q2 | 19.12 Million CNY | 57.41% |
| 2015 Q1 | 12.15 Million CNY | 3.12% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | 11.78 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 11.78 Million CNY | 165.65% |
| 2014 Q3 | 4.43 Million CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -1020321.967% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -4618.663% |
| Biocept, Inc. | 10.37 Million USD | -490.124% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | -19.329% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -11106.778% |
| iMD Companies, Inc. | 1.1 Million USD | -5447.45% |
| IDenta Corp. | 428.17 Thousand USD | -14199.101% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -1342.972% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -21923.496% |
| NovelStem International Corp. | 3.32 Million USD | -1741.585% |
| Optigenex Inc. | 4.42 Million USD | -1282.977% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -3653.852% |
| Response Genetics, Inc | 4.91 Million USD | -1144.923% |
| Rennova Health, Inc. | 359.19 Thousand USD | -16945.243% |
| RushNet, Inc. | 4.25 Million USD | -1339.786% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -24483.545% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -7568.108% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -10522.351% |
| Todos Medical Ltd. | 33 Million USD | -85.526% |